Alvotech settles with AbbVie to secure US rights to Humira biosimilar

Alvotech expects AVT02 (adalimumab) will be marketed in the U.S., subject to regulatory approval, on July 1, 2023

AbbVie acquires Syndesi Therapeutics, strengthening neuroscience portfolio

Expands AbbVie's neuroscience portfolio, adding first-in-class modulators of the synaptic vesicle protein 2A, including lead molecule SDI-118 currently in Phase 1b studies

Roche signs up to $2.3 billion deal with Nurix for BTK degrader Bexobrutideg

The agreement underscores Roche’s commitment to advancing innovative therapies for blood cancers and other serious diseases

Glenmark posts strong FY26 results with 27.5% revenue jump

EU regulator backs Allergan Aesthetics’ Boey in key step toward approval

The decision marks a key step in the centralized EU review process

Alembic Pharma receives USFDA nod for generic Levothyroxine sodium tablets

Approved product is therapeutically equivalent to Synthroid of AbbVie and is indicated for the treatment of congenital or acquired hypothyroidism

IGI’s new drug candidate ISB 2301 to target solid tumors

The company intends to file an IND submission by the end of this year and begin clinical studies in 2027

Allergan Aesthetics ties referrals to skin cancer awareness month with $100,000 donation drive

The initiative pairs consumer engagement with a public health message about prevention and early detection

Erin Lichy teams with Allergan Aesthetics to open up about breast augmentation

Through the partnership, she plans to share her experience—from consultation through recovery—across her social media platforms

BOTOX Cosmetic launches programme to empower 250 women entrepreneurs

20 among them to receive $20,000 grants